Clinical Trial Update: CNS Uptake of Intranasal Glutathione [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluating CNS uptake of intranasal glutathione in Parkinson's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Intranasal glutathione (glutathione)

Snippet

Sponsor: University of Washington | Conditions: Parkinson's Disease | Phase 1 | Status: COMPLETED